Acromegaly and diffuse multinodular goiter: clinical cases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Acromegaly is a severe neuroendocrine disease associated with increased production of growth hormone by cells of the adenohypophysis. Many authors have shown that the thyroid pathology in patients with pituitary adenomas producing somatotropic hormone (STH) occurs more often than the population, and mixed (diffuse-nodular or diffuse-multinodular) goiter is the most common thyroid disease. A series of clinical cases. In the available literature, we did not find a description of the development of a goiter with airway obstruction and pronounced dislocation of the neck organs in patients with acromegaly, and therefore we present two clinical cases of giant diffuse multinodular goiter against the background of prolonged growth hormone hyperproduction. In the presented cases, the continued growth of the thyroid gland against the background of acromegaly was associated with the patients’ lack of compliance and refusal of both neurosurgical and conservative treatment. Conclusion. Currently, thyroid pathology is not included in a number of clinical manifestations of acromegaly, and therefore there are no recommendations for appropriate screening of such patients. Patients with STH-producing pituitary adenomas are at risk of developing giant multinodular goiter with the further development of life-threatening tracheal stenosis. This fact can serve as a sufficient reason for ultrasound examination of the thyroid gland in patients with somatotropinomas already at the stage of primary diagnosis of the disease. Timely treatment of STH-producing tumors of the pituitary gland will eliminate the effect of growth hormone on nodulation and an increase in the thyroid gland volume and, accordingly, avoid compression of the neck organs.

Full Text

Restricted Access

About the authors

V. F Rusakov

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

Dina V. Rebrova

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

Email: endocrinology@list.ru
Cand. Sci. (Med.). 154, Fontanka river embankment, St. Petersburg 190103, Russian Federation

N. I Timofeeva

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

A. A Belousova

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

T. V Savelyeva

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

R. A Chernikov

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

I. V Sleptsov

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

T. S Pridvizhkina

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

N. V Vorokhobina

North-Western State Medical University n.a. I.I. Mechnikov

St. Petersburg, Russia

Yu. N Fedotov

N.I. Pirogov Clinic of High Medical Technologies Saint Petersburg State University

St. Petersburg, Russia

References

  1. Клинические рекомендации «Акромегалия: клиника, диагностика, дифференциальная диагностика, методы лечения». 2014.
  2. Чих И.Д., Триголосова И.В., Древаль А.В., Триголосов А.В. Новообразования при акромегалии. Альманах клинической медицины. 2016;44(5):568-79. doi: 10.18786/2072-0505-2016-44-5-568-579.
  3. Gasperi M., Martino E., Manetti L., et al. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Investig. 2002;25(3):240-45. Doi: 10.1007/ BF03343997.
  4. Князева О.В., Молитвословова Н.Н., Рожинская Л.Я. Частота выявляемости новообразований щитовидной железы у пациентов с акромегалией. Клиническая и экспериментальная тиреоидология. 2015;11(3):34-8. doi: 10.14341/ket2015334-38.
  5. Rogozinski A., Furioso A., Glikman P., et al. Thyroid nodules in acromegaly Arq Bras Endocrinol Metabol. 2012;56(5):300-4. Doi: 10.1590/ s0004-27302012000500004.
  6. Xu D., Wu B., Li X., et al. Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas. Endocrine Disorders. 2;19(1):94. doi: 10.1186/s12902-019-0424-x.
  7. Lai N.B., Garg D., Heaney A.P., et al. No benefit of dedicated thyroid nodule screening in patients with acromegaly. Endocr Pract. 2020;26(1):16-21. doi: 10.4158/EP-2019-0254.
  8. Cheung N.W., Boyages S.C. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf). 1997;46(5):545-49. doi: 10.1046/j.1365-2265.1997.1680985.x.
  9. Herrmann B.L., Baumann H., Janssen O.E. et al. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes. 2004;112(5):225-30. doi: 10.1055/s-2004-817967.
  10. Dogan S., Atmaca A., Dagdelen S., et al. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine. 2014;45(1):114-21. doi: 10.1007/s12020-013-9981-3.
  11. Князева О.В. Предикторы и частота развития новообразований щитовидной железы и желудочно-кишечного тракта у пациентов с акромегалией: Автореф. дисс. канд. мед. наук. М., 2016.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies